机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, and Collaborative InnovationCenter for Biotherapy, Chengdu, China四川大学华西医院[2]Key Laboratory of Bio-resources and Eco-environment, Ministry of Education, College of Life Sciences, SichuanUniversity, Chengdu, China[3]Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics,Chengdu University, Chengdu, China[4]State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospitalof Stomatology, Sichuan University, Chengdu, China[5]Department of Pathogenic Biology, College of Preclinical Medicine, Southwest Medical University,Luzhou, China[6]Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院
Pseudomonas aeruginosa is a versatile Gram-negative pathogen with intricate intracellular regulatory networks that enable it to adapt to and flourish in a variety of biotic and abiotic habitats. However, the mechanism permitting the persistent survival of P. aeruginosa within host tissues and causing chronic symptoms still remains largely elusive. By using in situ RNA sequencing, here we show that P. aeruginosa adopts different metabolic pathways and virulence repertoires to dominate the progression of acute and chronic lung infections. Notably, a virulence factor named TesG, which is controlled by the vital quorum-sensing system and secreted by the downstream type I secretion system, can suppress the host inflammatory response and facilitate the development of chronic lung infection. Mechanically, TesG can enter the intracellular compartment of macrophages through clathrin-mediated endocytosis, competitively inhibit the activity of eukaryotic small GTPase and thus suppress subsequent neutrophil influx, cell cytoskeletal rearrangement of macrophages and the secretion of cytokines and chemokines. Therefore, the identification of TesG in this study reveals a type I secretion apparatus of P. aeruginosa that functions during the host-pathogen interaction, and may open an avenue for the further mechanistic study of chronic respiratory diseases and the development of antibacterial therapy.
基金:
This work is supported by the National Natural Science Foundation of China
(no. 31700111 to K.Z., no. 81302371 and no. 81672675 to Jing Li, no. 81202324 to
X. Zhou and no. 31570534 to X. Zhang), the Excellent Young Scientist Foundation of
Sichuan University (no. 2017SCU04A16 to X. Zhou), the Innovative Spark Foundation
of Sichuan University (no. 2018SCUH0032 to X. Zhou) and the National Major Scientific
and Technological Special Project for ‘Significant New Drugs Development’
(no. 2018ZX09201018-013 to X. Zhou).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|1 区生物学
小类|1 区微生物学
最新[2023]版:
大类|1 区生物学
小类|1 区微生物学
第一作者:
第一作者机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, and Collaborative InnovationCenter for Biotherapy, Chengdu, China[2]Key Laboratory of Bio-resources and Eco-environment, Ministry of Education, College of Life Sciences, SichuanUniversity, Chengdu, China[3]Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics,Chengdu University, Chengdu, China
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Kelei,Li Wujiao,Li Jing,et al.TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection.[J].Nature microbiology.2019,4(3):459-469.doi:10.1038/s41564-018-0322-4.
APA:
Zhao Kelei,Li Wujiao,Li Jing,Ma Teng,Wang Kailun...&Zhou Xikun.(2019).TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection..Nature microbiology,4,(3)
MLA:
Zhao Kelei,et al."TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection.".Nature microbiology 4..3(2019):459-469